Rubella surveillance no. 3, October 1971
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Rubella surveillance no. 3, October 1971
Filetype[PDF-12.11 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Rubella surveillance no. 3, October 1971
Details:
  • Corporate Authors:
    Center for Disease Control
  • Content Notes:
    I. Introduction -- II. Recent Trends: A. Source of Data; B. Reported Rubella; C. Serological Survey for Rubella Immunity Among Adolescents. -- III. Congenital Rubella Syndrome Surveillance -- IV. Surveillance of Vaccine Use -- V. Reported Complications Associated with Administration of Rubella Vaccine: A. Joint Reactions; B. Central Nervous System reactions occurring within 30 days after rubella vaccine inoculation; C. Inadvertent vaccination during pregnancy. -- VI. Special Investigations: -- A. Bermuda; B. Casper, Wyoming; C. Gillette, Wyoming; D. Grand Isle, Louisiana; E. Kauai, Hawaii. -- VII. Appendix A. Rubella Case Investigations Report; Appendix B. Congenital Rubella Syndrome Case Report Form; Appendix C. Serologic Assistance in Rubella Diagnosis; Appendix D. Recommendations for Use.
  • Subject:
  • Document Type:
    Report
  • Place as Subject:
    United States
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 10.37 MB]
    Corporate Authors:
    Center for Disease Control.
    Published Date:
    AUGUST 1970
    Series:
    Rubella surveillance ; no. 2
    Description:
    In June 1969, a live attenuated rubella virus vaccine was licensed for use in the United States. Subsequently, two other rubella vaccines have been licensed. Thus, rubella vaccine has become available 28 years after the recognition of the etiologic r...
    File Type:
    Filetype[PDF - 10.37 MB]
  2. Filetype[PDF - 18.84 MB]
    Corporate Authors:
    Center for Disease Control. United States. Public Health Service. Advisory Committee on Immunization Practices..
    Published Date:
    Issued May 1980
    Series:
    Rubella surveillance summary
    File Type:
    Filetype[PDF - 18.84 MB]
  3. Filetype[PDF - 10.37 MB]
    Corporate Authors:
    Center for Disease Control
    Published Date:
    August 1970
    Series:
    Rubella surveillance ; no. 2
    Description:
    Summarized in this report is information received from state and local health departments and other pertinent sources. Much of the information is preliminary. It is intended primarily for the use of those with responsibility for disease control activ...
    File Type:
    Filetype[PDF - 10.37 MB]
  4. Filetype[PDF - 9.23 MB]
    Corporate Authors:
    National Communicable Disease Center (U.S.)
    Published Date:
    June 1969
    Series:
    Rubella surveillance ; no. 1
    Description:
    Summarized in this report is information received from state and local health departments and other pertinent sources. Much of the information is preliminary. It is intended primarily for the use of those with responsibility for disease control activ...
    File Type:
    Filetype[PDF - 9.23 MB]
  5. Filetype[PDF - 204.15 KB]
    Personal Author:
    McCauley, Mary M.; Pope, Alice E.; Reef, Susan E.; Smith, Sheree F.; West, Beth Rowe; Zimmerman, Laura A.;
    Corporate Authors:
    National Immunization Program (Centers for Disease Control and Prevention). Centers for Disease Control and Prevention (U.S.). North Carolina. Women's and Children's Health Section..
    Published Date:
    July 13, 2001
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 50, no. RR-12
    Description:
    Outbreaks of rubella continue to occur in the United States despite widespread use of the measles-mumps-rubella (MMR) vaccine. Throughout the mid- to late-1990s, rubella outbreaks were characterized by increased numbers of cases among adults born in ...
    File Type:
    Filetype[PDF - 204.15 KB]